Acumen Pharmaceuticals, Inc. ABOS
NASDAQ · United States · Health Technology
$2.03-0.04 (-2.17%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.45 | -0.36 | -25.2% | $0 | — | +3.2%$2.47→$2.55 |
| Q1 2026 | 2026-05-12 | -0.33 | -0.46 | +28.3% | — | — | -3.1%$2.57→$2.49 |
| Q4 2025 | 2026-03-26 | -0.41 | -0.56 | +26.8% | — | — | -14.1%$2.63→$2.26 |
| Q3 2025 | 2025-11-12 | -0.44 | -0.63 | +30.2% | — | — | -8.1%$1.97→$1.81 |
| Q2 2025 | 2025-08-12 | -0.68 | -0.52 | -30.8% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.62 | -0.37 | -67.6% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.34 | -0.25 | -36.0% | — | — | — |
| Q1 2024 | 2024-05-14 | -0.25 | -0.23 | -8.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.